Account

Sign in to access your account and subscription

Should the Heeding Presumption Apply to Pharmaceutical Failure-to-Warn Claims? PA Court Says 'No'

Part One of this series discussed the rationales courts typically draw upon in deciding whether to apply a heeding presumption in failure-to-warn cases in general. This installment analyzes the application of the heeding presumption in pharmaceutical failure-to-warn cases specifically and explains why justifications for the presumption in the general product liability context do not necessarily hold true in the pharmaceutical failure-to-warn setting.

39 minute readMay 31, 2006 at 10:22 AM
By
Heather Ritch
Krista Schmid
Should the Heeding Presumption Apply to Pharmaceutical Failure-to-Warn Claims? PA Court Says 'No'

Part Two of a Two-Part Series

Part One of this series discussed the rationales courts typically draw upon in deciding whether to apply a heeding presumption in failure-to-warn cases in general.

This premium content is locked for LawJournalNewsletters subscribers only

ENJOY UNLIMITED ACCESS TO THE SINGLE SOURCE OF OBJECTIVE LEGAL ANALYSIS, PRACTICAL INSIGHTS, AND NEWS IN LawJournalNewsletters

  • Stay current on the latest information, rulings, regulations, and trends
  • Includes practical, must-have information on copyrights, royalties, AI, and more
  • Tap into expert guidance from top entertainment lawyers and experts

Already have an account? Sign In Now

For enterprise-wide or corporate access, please contact Customer Service at [email protected] or call 1-877-256-2473.

NOT FOR REPRINT

© 2026 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.

Continue Reading

The volume and sophistication of work hitting law firm marketing departments is accelerating. That moves the burden from responding to being ready: ready with differentiated positioning, ready with competitive intelligence, ready to get a compelling pitch to the right client before a formal process even begins. That requires more sophisticated output, produced faster, by teams that are already stretched past capacity.

April 01, 2026

The annals of copyright decisions could provide a reasonably representative catalog of what our culture has been up to over the past 200 years. A Feb. 3 decision from the Southern District of New York is a case in point. It involves a sex-trafficking conspiracy, Tweets attacking a troubled crypto firm, and a claimed transfer of copyright ownership through a restitution order in a criminal case, all over an undercurrent of competing First Amendment and victim-privacy concerns.

April 01, 2026

Matthew McConaughey secured eight federal trademark registrations covering his voice and iconic catchphrases in a novel legal strategy aimed at combating AI’s unauthorized use of his voice and likeness. The move signals an important evolution in the power dynamics between talent/brands and the companies providing generative AI tools.

April 01, 2026